Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?

Londoùo MC, Gratacós-Ginès J, Såez-Peùataro J

SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools.

Cooper DM, Zulu MZ, Jankeel A, Ibraim IC, Ardo J, Kasper K, Stephens D, Meyer A, Stehli A, Condon C, LondoĂąo ME, Schreiber CM, Lopez NV, Camplain RL, Weiss M, Golden C, Radom-Aizik S, Boden-Albala B, Chau C, Messaoudi I, Ulloa ER

BJS commission on surgery and perioperative care post-COVID-19.

BJS Commission Team

Formulation and Characterization of a New Injectable Bone Substitute Composed PVA/Borax/CaCO(3) and Demineralized Bone Matrix.

Medrano-David D, Lopera AM, LondoĂąo ME, Araque-MarĂ­n P

Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.

Ferre-Aracil C, Riveiro-Barciela M, Trapero-Marugån M, Rodríguez-Perålvarez M, Llovet LP, TÊllez L, Sånchez-Torrijos Y, Díaz-Fontenla F, Salcedo-Plaza M, Álvarez-López P, de la Mata M, Londoùo MC, Baùares-Caùizares R, Calleja JL

Translation and Cultural Adaptation of the Ages and Stages Questionnaires (ASQ) Worldwide: A Scoping Review.

Rousseau M, Dionne C, Savard RT, Schonhaut L, Londono M

Impact of donor extracellular vesicle release on recipient cell "cross-dressing" following clinical liver and kidney transplantation.

Mastoridis S, LondoĂąo MC, Kurt A, Kodela E, Crespo E, Mason J, Bestard O, MartĂ­nez-Llordella M, SĂĄnchez-Fueyo A

SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four Diverse Schools.

Cooper DM, Zulu MZ, Jankeel A, Ibraim IC, Ardo J, Kasper K, Stephens D, Meyer A, Stehli A, Condon C, LondoĂąo ME, Schreiber CM, Lopez NV, Camplain RL, Weiss M, Golden C, Aizik S, Boden-Albala B, Chau C, Messaoudi I, Ulloa ER

A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.

Sarmiento-Monroy JC, Espinosa G, Londoùo MC, Meira F, Caballol B, Llufriu S, Carrasco JL, Moll-Udina A, Quintana LF, Giavedoni P, Ramírez J, Inciarte-Mundo J, Solana E, Blanco Y, Martinez-Hernandez E, Sepúlveda M, Llorenç V, Prieto-Gonzålez S, Espígol-FrigolÊ G, Milisenda JC, Cid MC, Mascaró JM Jr, Blanco I, Barberå JA, Sibila O, Gratacos-Ginès J, Adån A, Agustí A, Sanmartí R, PanÊs J, Cervera R, Vila J, Soriano A, Gómez-Puerta JA, Immunocovid Clinic

On the impact of hepatitis C virus and heterologous immunity on alloimmune responses following liver transplantation.

Merritt E, LondoĂąo MC, Childs K, Whitehouse G, Kodela E, SĂĄnchez-Fueyo A, MartĂ­nez-Llordella M

Improvement of sexuality after hepatitis C cure with direct acting antivirals.

MariĂąo Z, RodrĂ­guez-Tajes S, BartrĂŠs C, NĂĄcar L, Lens S, NavinĂŠs R, Cavero M, LondoĂąo MC, Sastre L, Pocurull A, Dafieno A, MartĂ­n-Santos R, Forns X

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8(+) T cells after direct-acting antiviral therapies.

Perpiùån E, PÊrez-Del-Pulgar S, Londoùo MC, Mariùo Z, Lens S, Leonel T, Bartres C, García-López M, Rodriguez-Tajes S, Forns X, Koutsoudakis G

Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.

RodrĂ­guez-Tajes S, Pocurull A, Castillo J, Casanova G, Vega L, Lens S, MariĂąo Z, LondoĂąo MC, Forner A, Torres F, Forns X

Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors.

LondoĂąo MC, Reig M, RETOINMUNO Multidisciplinary Group

Comparison of immediate colposcopy, repeat conventional cytology and hrHPV testing for the clinical management of ASC-US cytology in routine health services of Medellin, Colombia: The ASCUS-COL Trial.

Baena A, Agudelo MC, Lopez C, RamĂ­rez AT, CastaĂąeda KM, Bedoya AM, Riveros M, Posada G, Borrero M, Buitrago CA, Suescun D, Gomez LJ, Ochoa JC, Stoler M, Gage J, Castle PE, Sasieni P, Almonte M, Herrero R, Sanchez GI, ASCUS-COL Trial Group